Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ZFAND2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PDE1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ELF5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
PENK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYL6B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LUC7L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC105372840 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ST7L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM50A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GATC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCAMP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPRY4-IT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KDM4C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TSPAN5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WHSC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARFGEF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on